The Cardiac POC Testing market is expected to grow from USD 1.92 billion in 2022 to USD 3.72 billion by 2032, at a CAGR of 6.84% during the forecast period 2023-2032.
Cardiac point-of-care (POC) testing typically involves using portable, handheld devices or test kits that healthcare professionals can efficiently operate. These tests are designed to provide rapid and accurate results, often within minutes, eliminating the need for time-consuming laboratory analysis. The immediate availability of test results allows healthcare providers to make informed decisions regarding patient management, such as initiating appropriate treatment or determining the need for further diagnostic tests or interventions.
The rising incidence of cardiovascular disorders, such as heart attacks and heart failure, is driving the growth of the cardiac POC testing market. These tests provide a quick and accurate diagnosis, enabling early intervention and better patient outcomes. Moreover, the shift towards decentralized testing is anticipated to witness significant opportunities over the forecast period for cardiac POC testing. With the growing emphasis on point-of-care delivery and patient-centred care, there is a need for rapid and accessible diagnostic solutions, making cardiac POC testing an attractive option. On the other hand, implementing cardiac POC testing can be expensive, requiring investment in specialized equipment and ongoing maintenance. This cost factor can limit the market's growth.
This study comprehensively analyses product type, end user, and region. The product type segment is classified into analyzers, cardiac markers test and others. The cardiac markers test segment held the highest market revenue in 2022. Cardiac marker tests have high sensitivity and specificity, which allow accurate detection and differentiation of cardiac disorders. They can identify subtle changes in cardiac biomarker levels, even in the early stages of a disease or in patients without evident symptoms. This accuracy is vital for prompt clinical decision-making, risk stratification, and appropriate patient management. The end user segment includes ambulatory surgical centres, diagnostic laboratories, research laboratories, hospitals and others. The hospitals segment held the highest market share in 2022. Hospitals are the primary centralized healthcare facilities where patients seek diagnosis, treatment, and management of cardiovascular diseases. They serve as the main point of care for patients with cardiac conditions, making them a natural hub for cardiac POC testing. Hospitals have the infrastructure, resources, and specialized healthcare professionals to perform cardiac POC testing effectively.
The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The Asia-Pacific region held the highest market revenue in 2022. The Asia-Pacific region has a high burden of cardiovascular diseases, including heart attacks, strokes, and heart failure. This region has witnessed a significant increase in these conditions in recent years, attributed to various factors such as sedentary lifestyles, changing dietary patterns, and an ageing population. The high prevalence of cardiovascular diseases drives the demand for cardiac POC testing in the region.
Some of the notable players in the market are LifeSign LLC, Medtronic plc, Nano-Ditech Corporation, Nexus Dx Inc., PTS Diagnostics, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Nova Biomedical Corporation, Trividia Health Inc., Sekisui Diagnostics, Nipro Corp., Trinity Biotech, Orasure Technologies, Inc., and Spectral Medical Inc. among others.
Report Description:
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Product Type
4.3.2. Market Attractiveness Analysis By End User
4.3.3. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Growing prevalence of cardiovascular diseases
5.3. Restraints
5.3.1. Cost constraints
5.4. Opportunities
5.4.1. Increasing demand for decentralized testing
5.5. Challenges
5.5.1. Quality control and standardization
6. Global Cardiac POC Testing Market Analysis and Forecast, By Product Type
6.1. Segment Overview
6.2. Analyzers
6.3. Cardiac Markers Test
6.4. Others
7. Global Cardiac POC Testing Market Analysis and Forecast, By End User
7.1. Segment Overview
7.2. Ambulatory Surgical Centres
7.3. Diagnostic Laboratories
7.4. Research Laboratories
7.5. Hospitals
7.6. Others
8. Global Cardiac POC Testing Market Analysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Cardiac POC Testing Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in Global Cardiac POC Testing Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Product Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. LifeSign LLC
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. Medtronic plc
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. Nano-Ditech Corporation
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. Nexus Dx Inc.
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. PTS Diagnostics
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. Bio-Rad Laboratories Inc.
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. Hoffmann-La Roche AG
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Product Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. Nova Biomedical Corporation
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Product Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
10.9. Trividia Health Inc.
10.9.1. Business Overview
10.9.2. Company Snapshot
10.9.3. Company Market Share Analysis
10.9.4. Company Product Portfolio
10.9.5. Recent Developments
10.9.6. SWOT Analysis
10.10. Sekisui Diagnostics
10.10.1. Business Overview
10.10.2. Company Snapshot
10.10.3. Company Market Share Analysis
10.10.4. Company Product Portfolio
10.10.5. Recent Developments
10.10.6. SWOT Analysis
10.11. Nipro Corp.
10.11.1. Business Overview
10.11.2. Company Snapshot
10.11.3. Company Market Share Analysis
10.11.4. Company Product Portfolio
10.11.5. Recent Developments
10.11.6. SWOT Analysis
10.12. Trinity Biotech
10.12.1. Business Overview
10.12.2. Company Snapshot
10.12.3. Company Market Share Analysis
10.12.4. Company Product Portfolio
10.12.5. Recent Developments
10.12.6. SWOT Analysis
10.13. Orasure Technologies, Inc.
10.13.1. Business Overview
10.13.2. Company Snapshot
10.13.3. Company Market Share Analysis
10.13.4. Company Product Portfolio
10.13.5. Recent Developments
10.13.6. SWOT Analysis
10.14. Spectral Medical Inc.
10.14.1. Business Overview
10.14.2. Company Snapshot
10.14.3. Company Market Share Analysis
10.14.4. Company Product Portfolio
10.14.5. Recent Developments
10.14.6. SWOT Analysis
List of Table
1. Global Cardiac POC Testing Market, By Product Type, 2019-2032 (USD Billion)
2. Global Analyzers, Cardiac POC Testing Market, By Region, 2019-2032 (USD Billion)
3. Global Cardiac Markers Test, Cardiac POC Testing Market, By Region, 2019-2032 (USD Billion)
4. Global Others, Cardiac POC Testing Market, By Region, 2019-2032 (USD Billion)
5. Global Cardiac POC Testing Market, By End User, 2019-2032 (USD Billion)
6. Global Ambulatory Surgical Centres, Cardiac POC Testing Market, By Region, 2019-2032 (USD Billion)
7. Global Diagnostic Laboratories, Cardiac POC Testing Market, By Region, 2019-2032 (USD Billion)
8. Global Research Laboratories, Cardiac POC Testing Market, By Region, 2019-2032 (USD Billion)
9. Global Hospitals, Cardiac POC Testing Market, By Region, 2019-2032 (USD Billion)
10. Global Others, Cardiac POC Testing Market, By Region, 2019-2032 (USD Billion)
11. Global Cardiac POC Testing Market, By Region, 2019-2032 (USD Billion)
12. North America Cardiac POC Testing Market, By Product Type, 2019-2032 (USD Billion)
13. North America Cardiac POC Testing Market, By End User, 2019-2032 (USD Billion)
14. U.S. Cardiac POC Testing Market, By Product Type, 2019-2032 (USD Billion)
15. U.S. Cardiac POC Testing Market, By End User, 2019-2032 (USD Billion)
16. Canada Cardiac POC Testing Market, By Product Type, 2019-2032 (USD Billion)
17. Canada Cardiac POC Testing Market, By End User, 2019-2032 (USD Billion)
18. Mexico Cardiac POC Testing Market, By Product Type, 2019-2032 (USD Billion)
19. Mexico Cardiac POC Testing Market, By End User, 2019-2032 (USD Billion)
20. Europe Cardiac POC Testing Market, By Product Type, 2019-2032 (USD Billion)
21. Europe Cardiac POC Testing Market, By End User, 2019-2032 (USD Billion)
22. Germany Cardiac POC Testing Market, By Product Type, 2019-2032 (USD Billion)
23. Germany Cardiac POC Testing Market, By End User, 2019-2032 (USD Billion)
24. France Cardiac POC Testing Market, By Product Type, 2019-2032 (USD Billion)
25. France Cardiac POC Testing Market, By End User 2019-2032 (USD Billion)
26. U.K. Cardiac POC Testing Market, By Product Type, 2019-2032 (USD Billion)
27. U.K. Cardiac POC Testing Market, By End User 2019-2032 (USD Billion)
28. Italy Cardiac POC Testing Market, By Product Type, 2019-2032 (USD Billion)
29. Italy Cardiac POC Testing Market, By End User 2019-2032 (USD Billion)
30. Spain Cardiac POC Testing Market, By Product Type, 2019-2032 (USD Billion)
31. Spain Cardiac POC Testing Market, By End User 2019-2032 (USD Billion)
32. Asia Pacific Cardiac POC Testing Market, By Product Type, 2019-2032 (USD Billion)
33. Asia Pacific Cardiac POC Testing Market, By End User 2019-2032 (USD Billion)
34. Japan Cardiac POC Testing Market, By Product Type, 2019-2032 (USD Billion)
35. Japan Cardiac POC Testing Market, By End User 2019-2032 (USD Billion)
36. China Cardiac POC Testing Market, By Product Type, 2019-2032 (USD Billion)
37. China Cardiac POC Testing Market, By End User 2019-2032 (USD Billion)
38. India Cardiac POC Testing Market, By Product Type, 2019-2032 (USD Billion)
39. India Cardiac POC Testing Market, By End User 2019-2032 (USD Billion)
40. South America Cardiac POC Testing Market, By Product Type, 2019-2032 (USD Billion)
41. South America Cardiac POC Testing Market, By End User 2019-2032 (USD Billion)
42. Brazil Cardiac POC Testing Market, By Product Type, 2019-2032 (USD Billion)
43. Brazil Cardiac POC Testing Market, By End User 2019-2032 (USD Billion)
44. Middle East and Africa Cardiac POC Testing Market, By Product Type, 2019-2032 (USD Billion)
45. Middle East and Africa Cardiac POC Testing Market, By End User 2019-2032 (USD Billion)
46. UAE Cardiac POC Testing Market, By Product Type, 2019-2032 (USD Billion)
47. UAE Cardiac POC Testing Market, By End User 2019-2032 (USD Billion)
48. South Africa Cardiac POC Testing Market, By Product Type, 2019-2032 (USD Billion)
49. South Africa Cardiac POC Testing Market, By End User 2019-2032 (USD Billion)
List of Figures
1. Global Cardiac POC Testing Market Segmentation
2. Global Cardiac POC Testing Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Cardiac POC Testing Market Attractiveness Analysis By Product Type
9. Global Cardiac POC Testing Market Attractiveness Analysis By End User
10. Global Cardiac POC Testing Market Attractiveness Analysis By Region
11. Global Cardiac POC Testing Market: Dynamics
12. Global Cardiac POC Testing Market Share By Product Type (2023 & 2032)
13. Global Cardiac POC Testing Market Share By End User (2023 & 2032)
14. Global Cardiac POC Testing Market Share By Regions (2023 & 2032)
15. Global Cardiac POC Testing Market Share By Company (2022)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.